+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium



Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium



Journal of Pharmaceutical Sciences 104(3): 840-849



This paper examines the opportunities and challenges facing the pharmaceutical industry in moving to a primarily "continuous processing"-based supply chain. The current predominantly "large batch" and centralized manufacturing system designed for the "blockbuster" drug has driven a slow-paced, inventory heavy operating model that is increasingly regarded as inflexible and unsustainable. Indeed, new markets and the rapidly evolving technology landscape will drive more product variety, shorter product life-cycles, and smaller drug volumes, which will exacerbate an already unsustainable economic model. Future supply chains will be required to enhance affordability and availability for patients and healthcare providers alike despite the increased product complexity. In this more challenging supply scenario, we examine the potential for a more pull driven, near real-time demand-based supply chain, utilizing continuous processing where appropriate as a key element of a more "flow-through" operating model. In this discussion paper on future supply chain models underpinned by developments in the continuous manufacture of pharmaceuticals, we have set out; The significant opportunities to moving to a supply chain flow-through operating model, with substantial opportunities in inventory reduction, lead-time to patient, and radically different product assurance/stability regimes. Scenarios for decentralized production models producing a greater variety of products with enhanced volume flexibility. Production, supply, and value chain footprints that are radically different from today's monolithic and centralized batch manufacturing operations. Clinical trial and drug product development cost savings that support more rapid scale-up and market entry models with early involvement of SC designers within New Product Development. The major supply chain and industrial transformational challenges that need to be addressed. The paper recognizes that although current batch operational performance in pharma is far from optimal and not necessarily an appropriate end-state benchmark for batch technology, the adoption of continuous supply chain operating models underpinned by continuous production processing, as full or hybrid solutions in selected product supply chains, can support industry transformations to deliver right-first-time quality at substantially lower inventory profiles.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057913552

Download citation: RISBibTeXText

PMID: 25631279

DOI: 10.1002/jps.24343


Related references

Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences 104(3): 792-802, 2016

Equipment and Analytical Companies Meeting Continuous Challenges May 20-21 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences 104(3): 821-831, 2015

Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences 104(3): 781-791, 2016

Control Systems Engineering in Continuous Pharmaceutical Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences 104(3): 832-839, 2015

Regulatory and Quality Considerations for Continuous Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences 104(3): 803-812, 2015

White Paper on Continuous Bioprocessing May 20-21 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences 104(3): 813-820, 2015

Achieving continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences 104(3): 779-780, 2016

How Development and Manufacturing Will Need to Be Structured-Heads of Development/Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences 104(3): 850-864, 2015

Regulatory Perspectives on Continuous Pharmaceutical Manufacturing: Moving From Theory to Practice: September 26-27, 2016, International Symposium on the Continuous Manufacturing of Pharmaceuticals. Journal of Pharmaceutical Sciences 106(11): 3199-3206, 2017

Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges. Internal Medicine Journal 48(5): 499-508, 2018

IT-enabled Community Health Interventions: Challenges, Opportunities, and Future Directions. Egems 2(3): 1117, 2014

Progressive challenges in horticultural supply chains: some future challenges. Acta Horticulturae (712(Vol.1)): 39-49, 2006

Developing supply chains in infant industries: opportunities and challenges. Chain management in agribusiness and the food industry Proceedings of the Fourth International Conference Wageningen, 25-26 May 2000: 589-598, 2000

Opportunities and Challenges in the Design and Analysis of Biomass Supply Chains. Environmental Management 56(6): 1397-1415, 2016

Sustainability in maritime supply chains: Challenges and opportunities for theory and practice. Transportation Research Part E: Logistics and Transportation Review 78: 1-2, 2015